维普期刊资源整合服务平台（V6.5）

523篇 您的检索式：作者名="WALLENTIN L"

选中清除导出查看参考文献查看引证文献引用追踪共27页首页上一页第1页下一页末页 /27 跳转

	题名	作者	年代	出处	被引量
1	急性冠状动脉综合征发生1个月后的生长分化因子15水平与主要出血风险增加相关显示文摘用双重抗血小板治疗的急性冠状动脉综合征(acutecoronarysyndromes,ACS)患者在初次就诊测量的生长分化因子15(growthdifferentiationfactor-15,GDF-15)与大出血相关。	Lindholm D Hagstrm E James SK Becker RC Cannon CP Himmelmann A Katus HA Maurer G López-Sendón JL Steg PG Storey RF Siegbahn A Wallentin L 刘莉叶鹏	2017	中华高血压杂志2017，25，5：	5
2	Relationship between intedeukin 6 and mortality in patients with unstable coronary artery diease:effects of an early invasive or noninvasive strategy显示文摘	Lindmark E Diderholm E Wallentin L	2001	JAMA2001，286，17：	1
3	Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes : a genetic substudy of the Plato trial 显示文摘	Ticagrelor versus clopidogrel in paN Engl J Med 2009 361(11): Wallentin L James S Storey RF	2010	Lancet2010，376，9749：	1
4	Ticagrelor versus clopidogrel in patients with acute coronary syndromes显示文摘	Wallentin L Becker RC Budaj A	2009	N EnglJ Med2009，361，：	1
5	Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial 显示文摘	Wallentin L Hijazi Z Andersson U	2014	Circulation2014，130，21：	1
6	Ticagrelor versus clopidogrel in patients with acute coronary syndromes显示文摘	Wallentin L Becker RC Budaj A	2009	N Engl J Med2009，361，11：	1
7	Persistant inhibition of platelet function during long- term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease显示文摘	Wallentin L	1991	Eur Heart J1991，12，：	1
8	Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease, effects of an early invasive or noninvasive strategy显示文摘	Lindmark E Diderholm E Wallentin L	2001	JAMA2001，286，：	1
9	Anticoagulants in heart disease: current status and perspectives 显示文摘	de Caterina R Husted S Wallentin L	2007	Eur Heart J2007，28，：	1
10	Ticagrelor versus Clopidogrel inpatients with acute coronary syndromes J显示文摘	Wallentin L Becker RC Budaj A	2009	N Engl J Med2009，361，：	1
11	Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study显示文摘	Lind L Wallentin L Kempf T	2009	Eur Heart J2009，30，：	1
12	Ticagrelor versus clopidogrel in patients with acute coronary syndromes显示文摘	WALLENTIN L BECKER RC BUDAJ A	2009	N Engl J Med2009，361，11：	1
13	Effect of CYP2C19 and ABCBI single nucleotide polymorphisms on outcomes of treat- ment with ticagrelor versus clopidogrel for acute coronary syndromes : a genetic substudy of the Plato trial显示文摘	WALLENTIN L JAMES S STOREY R F	2010	Lancet2010，376，9749：	1
14	Ticagrelor versus clopidogrel inpatients with acute coronary syndromes显示文摘	Wallentin L Becker R C Budaj A	2009	New England Journal of Medicine2009，361，11：	1
15	Tieagrelor versus clopidogrel in patients with acutecoronary syndromes 显示文摘	Wallentin L Beeker RC Budaj A	2009	N Engl J Med2009，361，11：	1
16	Growth-differentiation factor 15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study显示文摘	Lind L Wallentin L Kempf T Tapken H Quint A Lindahl B	2009	Eur Heart J2009，30，：	1
17	Accessing the mental space-spatial working memory processes for language and vision overlap in preeuneus显示文摘	Wallentin M Weed E Ostergaard L	2008	Hum Brain Mapp2008，29，：	1
18	Ticagrelor versus clopi- dogrel in patients with acute coronary syndromes 显示文摘	Wallentin L Becker RC Budaj A	2009	N Engl J Med2009，361，11：	1
19	Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: A collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 Trials ( FIR ) 显示文摘	Damman P Wallentin L Fox KA	2012	Circulation2012，125，4：	1
20	Oral ximelagatran for secondary prophylaxis after myocardial infarction:the ESTEEM randomised controlled trial显示文摘	Wallentin L Wilcox RG Weaver WD	2003	Lancet2003，362，9386：	1

返回顶部每页显示：

共27页首页上一页第1页下一页末页 /27 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示